References
- Schueepp KG, Devadason SG, Roller C, et al. Aerosol delivery of nebulised budesonide in young children with asthma. Respir med. 2009;103(11):1738–1745. DOI:10.1016/j.rmed.2009.04.029
- Amirav I, Newhouse MT, Newhouse M. Deposition of small particles in the developing lung. Paediatr Respir Rev. 2012;13:73–78.
- Schüepp KG, Straub D, Möller A, et al. Deposition of aerosols in infants and children. J Aerosol Med. 2004;17(2):153–156. DOI:10.1089/0894268041457228
- Janssens HM, HAWM T. Aerosol therapy: the special needs of young children. Paediatr Respir Rev. 2006;7:83–85.
- Batchelor HK, Marriott JF. Formulations for children: problems and solutions. Br J Clin Pharmacol. 2015;79(3):405–418.
- Fink JB. Delivery of inhaled drugs for infants and small children: a commentary on present and future needs. Clin Ther. 2012;34(11):S36–45.
- Amirav I, Newhouse MT. Aerosol therapy in infants and toddlers: past, present and future. Expert Rev Respir Med. 2014;2(5):597–605. DOI:10.1586/17476348.2.5.597
- Ahrens RC. The role of the MDI and DPI in pediatric patients: “children are not just miniature adults. Respir Care. 2005;50(10):1323–1330.
- Amirav I, Newhouse MT, Minocchieri S, et al. Factors that affect the efficacy of inhaled corticosteroids for infants and young children. J Allergy Clin Immunol. 2010;125(6):1206–1211. DOI:10.1016/j.jaci.2010.01.034
- Poorbahrami K, Vignon-Clementel IE, Shadden SC, et al. A whole lung in silico model to estimate age dependent particle dosimetry. Sci Rep. 2021;11:1–12. DOI:10.1038/s41598-021-90509-8
- Das P, Nof E, Amirav I, et al. Targeting inhaled aerosol delivery to upper airways in children: insight from computational fluid dynamics (CFD). PLoS ONE. 2018;13(11):1–20. DOI:10.1371/journal.pone.0207711
- Oakes JM, Roth SC, Shadden SC, et al. Airflow simulations in infant, child, and adult pulmonary conducting airways. Ann Biomed Eng. 2018;46(3):498–512. DOI:10.1007/s10439-017-1971-9
- Weers J, Clark A. The impact of inspiratory flow rate on drug delivery to the lungs with dry powder inhalers. Pharm Res. 2017;34(3):507–528.
- Bass K, Farkas D, Hassan A, et al. High-efficiency dry powder aerosol delivery to children: review and application of new technologies. J Aerosol Sci. 2021;153:105692. DOI:10.1016/j.jaerosci.2020.105692
- Tian G, Longest PW, Li X, et al. Targeting aerosol deposition to and within the lung airways using excipient enhanced growth. J Aerosol Med Pulm Drug Deliv. 2013;26(5):248–265. DOI:10.1089/jamp.2012.0997
- Dolovich MB. Influence of inspiratory flow rate, particle size, and airway caliber on aerosolized drug delivery to the lung. Respir Care. 2000;45(6):597–608.
- Anhoi J, Bisgaard H, Thorsson L. Lung deposition of inhaled drugs increases with age. Am J Respir Crit Care Med. 2000;162(5):1819–1822.
- Janssens HM, De Jongste JC, Hop WCJ, et al. Extra-fine particles improve lung delivery of inhaled steroids in infants: a study in an upper airway model. Chest. 2003;123(6):2083–2088. DOI:10.1378/chest.123.6.2083